Your browser doesn't support javascript.
loading
A fine-tuned composition of protein nanofibrils yields an upgraded functionality of displayed antibody binding domains.
Schmuck, Benjamin; Sandgren, Mats; Härd, Torleif.
Afiliación
  • Schmuck B; Department of Molecular Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Sandgren M; Department of Molecular Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
  • Härd T; Department of Molecular Sciences, Swedish University of Agricultural Sciences, Uppsala, Sweden.
Biotechnol J ; 12(6)2017 Jun.
Article en En | MEDLINE | ID: mdl-28371185
Elevated performance of instruments and electronic devices is frequently attained through miniaturization of the involved components, which increases the number of functional units in a given volume. Analogously, to conquer the limitations of materials used for the purification of monoclonal antibodies and for the sensitivity of immunoassays, the support for capturing antibodies requires miniaturization. A suitable scaffold for this purpose are cross-ß structured protein nanofibrils, as they offer a superior surface area over volume ratio and because manipulation can be implemented genetically. To display the antibody binding Z-domain dimers (ZZ) along the surface of the fibrils and grant maximal accessibility to the functional units, the N-terminal fragments of the fibrillating translation release factor Sup35 or ureidosuccinate transporter Ure2, both from Saccharomyces cerevisae, are simultaneously fibrillated with the chimeric-proteins Sup35-ZZ and ZZ-Ure2, respectively. Optimization of the fibril composition yields a binding capacity of 1.8 mg antibody per mg fibril, which is a binding capacity that is almost 20-fold higher, compared to the commercially available affinity medium gold standard, protein A sepharose. This study lifts the craft of nanofibril functionalization to the next level, and offers a universal framework to improve biomaterials that rely on the display of functional proteins or enzymes.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Saccharomyces cerevisiae / Priones / Factores de Terminación de Péptidos / Proteínas de Saccharomyces cerevisiae / Glutatión Peroxidasa / Anticuerpos Monoclonales Idioma: En Revista: Biotechnol J Asunto de la revista: BIOTECNOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Alemania

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Saccharomyces cerevisiae / Priones / Factores de Terminación de Péptidos / Proteínas de Saccharomyces cerevisiae / Glutatión Peroxidasa / Anticuerpos Monoclonales Idioma: En Revista: Biotechnol J Asunto de la revista: BIOTECNOLOGIA Año: 2017 Tipo del documento: Article País de afiliación: Suecia Pais de publicación: Alemania